BBNX logo

Beta Bionics, Inc. (BBNX) Free Cash Flow

Annual FCF:

-$51.67M-$18.82M(-57.30%)
December 31, 2024

Summary

  • As of today, BBNX annual free cash flow is -$51.67 million, with the most recent change of -$18.82 million (-57.30%) on December 31, 2024.
  • During the last 3 years, BBNX annual free cash flow has risen by +$9.31 million (+15.27%).
  • BBNX annual free cash flow is now -57.30% below its all-time high of -$32.85 million, reached on December 31, 2023.

Performance

1-Year Change

-57.3%

3-Year Change

+15.27%

5-Year Change

+15.27%

15-Year Change

+15.27%

BBNX Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

26.77%
BBNX annual free cash flow is higher than 26.77% of companies in Healthcare sector

Range

All-Time High

-$32.85M
BBNX annual free cash flow is currently -57.30% below its historical high of -$32.85 million

3-Year Low

-$60.98M
BBNX annual free cash flow is currently +15.27% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
BBNX previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 24, 2026
BBNX next annual earnings announcement is scheduled for Mar 24, 2026

OtherBBNXcash flow metrics

Annual CFO

-$48.27M
BBNX annual cash from operations is -$48.27 million

Annual CFF

$55.62M
BBNX annual cash from financing is $55.62 million

Annual CFI

-$3.48M
BBNX annual cash from investing is -$3.48 million

Annual CAPEX

$3.40M
BBNX annual capital expenditures is $3.40 million

Quarterly FCF:

-$10.01M+$5.36M(+34.88%)
September 30, 2025

Summary

  • As of today, BBNX quarterly free cash flow is -$10.01 million, with the most recent change of +$5.36 million (+34.88%) on September 30, 2025.
  • Over the past year, BBNX quarterly free cash flow has increased by +$1.52 million (+13.20%).
  • BBNX quarterly free cash flow is now -50.32% below its all-time high of -$6.66 million, reached on December 31, 2023.

Performance

3-Month Change

+34.88%

1-Year Change

+13.2%

3-Year Change

-

5-Year Change

-

BBNX Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

30.03%
BBNX quarterly free cash flow is higher than 30.03% of companies in Healthcare sector

Range

All-Time High

-$6.66M
BBNX quarterly free cash flow is currently -50.32% below its historical high of -$6.66 million

3-Year Low

-$20.31M
BBNX quarterly free cash flow is currently +50.70% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
BBNX previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 24, 2026
BBNX next earnings announcement is scheduled for Mar 24, 2026

OtherBBNXcash flow metrics

Quarterly CFO

-$8.73M
BBNX quarterly cash from operations is -$8.73 million

Quarterly CFF

$2.65M
BBNX quarterly cash from financing is $2.65 million

Quarterly CFI

$9.49M
BBNX quarterly cash from investing is $9.49 million

Quarterly CAPEX

$1.28M
BBNX quarterly capital expenditures is $1.28 million

TTM FCF:

-$60.53M+$1.52M(+2.45%)
September 30, 2025

Summary

  • As of today, BBNX TTM free cash flow is -$60.53 million, with the most recent change of +$1.52 million (+2.45%) on September 30, 2025.
  • Over the past year, BBNX TTM free cash flow has dropped by -$17.04 million (-39.19%).
  • BBNX TTM free cash flow is now -808.89% below its all-time high of -$6.66 million, reached on December 31, 2023.

Performance

3-Month Change

+2.45%

1-Year Change

-39.19%

3-Year Change

-

5-Year Change

-

BBNX TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

24.66%
BBNX TTM free cash flow is higher than 24.66% of companies in Healthcare sector

Range

All-Time High

-$6.66M
BBNX TTM free cash flow is currently -808.89% below its historical high of -$6.66 million

3-Year Low

-$62.05M
BBNX TTM free cash flow is currently +2.45% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
BBNX previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 24, 2026
BBNX next earnings announcement is scheduled for Mar 24, 2026

OtherBBNXcash flow metrics

TTM CFO

-$56.58M
BBNX TTM cash from operations is -$56.58 million

TTM CFF

$270.71M
BBNX TTM cash from financing is $270.71 million

TTM CFI

-$193.13M
BBNX TTM cash from investing is -$193.13 million

TTM CAPEX

$3.96M
BBNX TTM capital expenditures is $3.96 million

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$51.67M
BBNX annual free cash flow is -$51.67 million

Annual CFO

-$48.27M
BBNX annual cash from operations is -$48.27 million

Annual CAPEX

$3.40M
BBNX annual capital expenditures is $3.40 million

BBNX Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-57.3%+13.2%-39.2%
3Y3 Years+15.3%--
5Y5 Years+15.3%--

BBNX Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-57.3%+15.3%-50.3%+50.7%-808.9%+2.5%
5Y5-Year-57.3%+15.3%-50.3%+50.7%-808.9%+2.5%
All-TimeAll-Time-57.3%+15.3%-50.3%+50.7%-808.9%+2.5%

BBNX Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2025
-
-$10.01M(+34.9%)
-$60.53M(+2.5%)
Jun 2025
-
-$15.37M(+24.3%)
-$62.05M(-4.4%)
Mar 2025
-
-$20.31M(-36.8%)
-$59.43M(-15.0%)
Dec 2024
-$51.67M
-$14.84M(-28.7%)
-$51.67M(-18.8%)
DateAnnualQuarterlyTTM
Sep 2024
-
-$11.53M(+9.5%)
-$43.49M(-36.1%)
Jun 2024
-
-$12.74M(-1.5%)
-$31.95M(-66.3%)
Mar 2024
-
-$12.55M(-88.4%)
-$19.21M(-188.4%)
Dec 2023
-$32.85M(+46.1%)
-$6.66M
-$6.66M
Dec 2022
-$60.98M
-
-

FAQ

  • What is Beta Bionics, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for Beta Bionics, Inc.?
  • What is Beta Bionics, Inc. annual free cash flow year-on-year change?
  • What is Beta Bionics, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Beta Bionics, Inc.?
  • What is Beta Bionics, Inc. quarterly free cash flow year-on-year change?
  • What is Beta Bionics, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for Beta Bionics, Inc.?
  • What is Beta Bionics, Inc. TTM free cash flow year-on-year change?

What is Beta Bionics, Inc. annual free cash flow?

The current annual free cash flow of BBNX is -$51.67M

What is the all-time high annual free cash flow for Beta Bionics, Inc.?

Beta Bionics, Inc. all-time high annual free cash flow is -$32.85M

What is Beta Bionics, Inc. annual free cash flow year-on-year change?

Over the past year, BBNX annual free cash flow has changed by -$18.82M (-57.30%)

What is Beta Bionics, Inc. quarterly free cash flow?

The current quarterly free cash flow of BBNX is -$10.01M

What is the all-time high quarterly free cash flow for Beta Bionics, Inc.?

Beta Bionics, Inc. all-time high quarterly free cash flow is -$6.66M

What is Beta Bionics, Inc. quarterly free cash flow year-on-year change?

Over the past year, BBNX quarterly free cash flow has changed by +$1.52M (+13.20%)

What is Beta Bionics, Inc. TTM free cash flow?

The current TTM free cash flow of BBNX is -$60.53M

What is the all-time high TTM free cash flow for Beta Bionics, Inc.?

Beta Bionics, Inc. all-time high TTM free cash flow is -$6.66M

What is Beta Bionics, Inc. TTM free cash flow year-on-year change?

Over the past year, BBNX TTM free cash flow has changed by -$17.04M (-39.19%)
On this page